| Sep 2, 2025 |
Sep 3, 2025 |
Spyre Therapeutics, Inc.
|
CFO |
Sell |
40.0
|
-18,428
|
-15.83%
|
✗
|
$299.6K |
| Sep 3, 2024 |
Sep 5, 2024 |
Spyre Therapeutics, Inc.
|
CFO |
Sell |
40.0
|
-18,531
|
-13.73%
|
✗
|
$522.1K |
| Mar 6, 2023 |
Mar 8, 2023 |
Arcutis Biotherapeutics, Inc.
|
CFO |
Sell |
53.8
|
-291
|
-0.49%
|
✓
|
$4.4K |
| Feb 28, 2023 |
Mar 2, 2023 |
Arcutis Biotherapeutics, Inc.
|
CFO |
Sell |
41.3
|
-1,850
|
-4.60%
|
✓
|
$29.4K |
| Mar 3, 2022 |
Mar 7, 2022 |
Arcutis Biotherapeutics, Inc.
|
CFO |
Sell |
90.0
|
+12,997
|
58.39%
|
✓
|
$5.1K |
| Mar 1, 2022 |
Mar 3, 2022 |
Arcutis Biotherapeutics, Inc.
|
CFO |
Sell |
50.0
|
-420
|
-1.85%
|
✓
|
$7.5K |
| Dec 27, 2021 |
Dec 28, 2021 |
Arcutis Biotherapeutics, Inc.
|
CFO |
Sell |
7.5
|
-12,560
|
-35.64%
|
✓
|
$252.1K |